Only a few studies have investigated disease progression in patients with early-onset Alzheimer’s disease (EOAD). Therefore, the aim of this study was to investigate disease progression in patients with EOAD and the influence of various factors, such as gender, education, and apolipoprotein E (APOE) genotype on disease progression.
Methods:
A total of 288 EOAD patients were enrolled in the study. Linear mixed models were used to investigate the rate of cognitive and functional decline in terms of age at onset, gender, education, follow-up period, and APOE genotype.
Results:
EOAD patients showed an annual decline of –1.54 points/years in the Korean version mini-mental examination score, an annual increase of 3.46 points/year in the Seoul instrumental activities of daily living (SIADL) score, and an annual increase of 1.15 points/year in the clinical dementia rating scale-sum of boxes score. After stratification, higher educated patients showed faster disease progression in all three parameters, and female patients demonstrated faster disease progression as assessed by the SIADL score. Age at onset and APOE genotype had no influence on disease progression.
Conclusion:
We confirmed the rate of disease progression in Korean patients with EOAD in real-life hospital-based clinical practice. The results of this study suggest that education and female gender, not APOE genotype, may be important as independent strong predictive factors for disease progression in patients with EOAD.
ToyotaYIkedaMShinagawaSMatsumotoTMatsumotoNHokoishiKFukuharaRIshikawaTMoriTAdachiHKomoriKTanabeH2007Comparison of behavioral and psychological symptoms in early-onset and late-onset Alzheimer’s diseaseInt J Geriatr Psychiatry22896901
2.
ShinagawaSIkedaMToyotaYMatsumotoTMatsumotoNMoriTIshikawaTFukuharaRKomoriKHokoishiKTanabeH2007Frequency and clinical characteristics of early-onset dementia in consecutive patients in a memory clinicDement Geriatr Cogn Disord244247
3.
AlbericiABenussiAPremiEBorroniBPadovaniA2014Clinical, genetic, and neuroimaging features of early onset Alzheimer disease: The challenges of diagnosis and treatmentCurr Alzheimer Res11909917
4.
SaFPintoPCunhaCLemosRLetraLSimoesMSantanaI2012Differences between early and late-onset Alzheimer’s disease in neuropsychological testsFront Neurol381
5.
ParkHKChoiSHParkSAKimHJLeeYHanSHKimEJKimBCHanHJMoonSYYangDWParkKWParkKHYoonBSeoSWNaDLNaHRLeeJH2015Cognitive profiles and neuropsychiatric symptoms in korean early-onset Alzheimer’s disease patients: A CREDOS studyJ Alzheimers Dis44661673
6.
SmitsLLPijnenburgYAKoedamELvan der VliesAEReulingIEKoeneTTeunissenCEScheltensPvan der FlierWM2012Early onset Alzheimer’s disease is associated with a distinct neuropsychological profileJ Alzheimers Dis30101108
7.
GourNFelicianODidicMKoricLGueriotCChanoineVConfort-GounySGuyeMCeccaldiMRanjevaJP2014Functional connectivity changes differ in early and late-onset Alzheimer’s diseaseHum Brain Mapp3529782994
8.
van der VliesAEStaekenborgSSAdmiraal-BehloulFPrinsNDBarkhofFVrenkenHReiberJHScheltensPvan der FlierWM2013Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset Alzheimer’s diseaseJ Alzheimers Dis35169178
9.
OssenkoppeleRZwanMDTolboomNvan AssemaDMAdriaanseSFKloetRWBoellaardRWindhorstADBarkhofFLammertsmaAAScheltensPvan der FlierWMvan BerckelBN2012Amyloid burden and metabolic function in early-onset Alzheimer’s disease: Parietal lobe involvementBrain13521152125
10.
de WaalHStamCJde HaanWvan StraatenECScheltensPvan der FlierWM2012Young Alzheimer patients show distinct regional changes of oscillatory brain dynamicsNeurobiol Aging331008e10251008e1031
11.
CanuEFrisoniGBAgostaFPievaniMBonettiMFilippiM2012Early and late onset Alzheimer’s disease patients have distinct patterns of white matter damageNeurobiol Aging3310231033
12.
JacobsDSanoMMarderKBellKBylsmaFLaflecheGAlbertMBrandtJSternY1994Age at onset of Alzheimer’s disease: Relation to pattern of cognitive dysfunction and rate of declineNeurology4412151220
13.
van der VliesAEKoedamELPijnenburgYATwiskJWScheltensPvan der FlierWM2009Most rapid cognitive decline in APOE epsilon4 negative Alzheimer’s disease with early onsetPsychol Med3919071911
14.
GronningHRahmaniAGyllenborgJDessauRBHoghP2012Does Alzheimer’s disease with early onset progress faster than with late onset? A case-control study of clinical progression and cerebrospinal fluid biomarkersDement Geriatr Cogn Disord33111117
15.
SeltzerBSherwinI1983A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two?Arch Neurol40143146
16.
PanegyresPKChenHY2013Differences between early and late onset Alzheimer’s disease.. eCollectionAm J Neurodegener Dis2300306eCollection 2013
17.
ZhaoQZhouBDingDTeramukaiSGuoQFukushimaMHongZ2014Cognitive decline in patients with Alzheimer’s disease and its related factors in a memory clinic setting, Shanghai, ChinaPLoS One9e95755
18.
WilsonRSGilleyDWBennettDABeckettLAEvansDA2000Person-specific paths of cognitive decline in Alzheimer’s disease and their relation to agePsychol Aging151828
19.
KatzmanRBrownTThalLJFuldPAAronsonMButtersNKlauberMRWiederholtWPayMXiongRB1988Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer’s diseaseAnn Neurol24384389
20.
HollandDDesikanRSDaleAMMcEvoyLK2013Higher rates of decline for women and apolipoprotein E epsilon4 carriersAJNR Am J Neuroradiol3422872293
21.
SakuraiHHanyuHSatoTKanetakaHShimizuSHiraoKKikukawaMIwamotoT2011Vascular risk factors and progression in Alzheimer’s diseaseGeriatr Gerontol Int11211214
22.
MusiccoMPalmerKSalamoneGLupoFPerriRMostiSSpallettaGdi IulioFPettenatiCCravelloLCaltagironeC2009Predictors of progression of cognitive decline in Alzheimer’s disease: The role of vascular and sociodemographic factorsJ Neurol25612881295
23.
McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEM1984Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s DiseaseNeurology34939944
24.
ParkHKNaDLHanSHKimJYCheongHKKimSYKimSYHongCHKimDKKuBDMoonSYLeeJYShimYSYounYCKimEJKimBCParkKHChaKRSeoSWLeeJH2011Clinical characteristics of a nationwide hospital-based registry of mild-to-moderate Alzheimer’s disease patients in Korea: A CREDOS (Clinical Research Center for Dementia of South Korea) studyJ Korean Med Sci2612191226
25.
KangYWNaDLHahnSH1997A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patientsJ Korean Neurol Assoc15300307
26.
MorrisJC1993The Clinical Dementia Rating (CDR): Current version and scoring rulesNeurology4324122414
AhnHJChinJParkALeeBHSuhMKSeoSWNaDL2010Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): A useful tool for assessing and monitoring cognitive impairments in dementia patientsJ Korean Med Sci2510711076
29.
MahoneyFIBarthelDW1965Functional evaluation: The barthel indexMd State Med J146165
30.
KuHKimJKwonEKimSLeeHKoHJoSKimD2004A study on the reliability and validity of Seoul-instrumental activities of daily living (S-IADL)J Korean Neuropsychiatr Assoc43189199
31.
BruandetARichardFBomboisSMaurageCAMasseIAmouyelPPasquierF2008Cognitive decline and survival in Alzheimer’s disease according to education levelDement Geriatr Cogn Disord257480
32.
YeBSSeoSWChoHKimSYLeeJSKimEJLeeYBackJHHongCHChoiSHParkKWKuBDMoonSYKimSHanSHLeeJHCheongHKNaDL2013Effects of education on the progression of early- versus late-stage mild cognitive impairmentInt Psychogeriatr25597606
33.
ClarkCMSheppardLFillenbaumGGGalaskoDMorrisJCKossEMohsRHeymanA1999Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: A clinical perspective of data from the Consortium to Establish a Registry for Alzheimer’s DiseaseArch Neurol56857862
34.
MorrisJCEdlandSClarkCGalaskoDKossEMohsRvan BelleGFillenbaumGHeymanA1993The consortium to establish a registry for Alzheimer’s disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer’s diseaseNeurology4324572465
35.
Gillette-GuyonnetSAndrieuSNourhashemiFGardetteVColeyNCantetCGauthierSOussetPJVellasB2011Long-term progression of Alzheimer’s disease in patients under antidementia drugsAlzheimers Dement7579592
36.
SuhGHJuYSYeonBKShahA2004A longitudinal study of Alzheimer’s disease: Rates of cognitive and functional declineInt J Geriatr Psychiatry19817824
37.
NourhashemiFOussetPJGillette-GuyonnetSCantetCAndrieuSVellasB2008A 2-year follow-up of 233 very mild (CDR 0.5) Alzheimer’s disease patients (REAL.FR cohort)Int J Geriatr Psychiatry23460465
38.
BozzaliMDowlingCSerraLSpanoBTorsoMMarraCCastelliDDowellNGKochGCaltagironeCCercignaniM2015The impact of cognitive reserve on brain functional connectivity in Alzheimer’s diseaseJ Alzheimers Dis44243250
39.
AmievaHMokriHLe GoffMMeillonCJacqmin-GaddaHFoubert-SamierAOrgogozoJMSternYDartiguesJF2014Compensatory mechanisms in higher-educated subjects with Alzheimer’s disease: A study of 20 years of cognitive declineBrain13711671175
40.
LoRYJagustWJ2013Effect of cognitive reserve markers on Alzheimer pathologic progressionAlzheimer Dis Assoc Disord27343350
41.
SternY2012Cognitive reserve in ageing and Alzheimer’s diseaseLancet Neurol1110061012
42.
FairjonesSEVuletichEJPestellCPanegyresPK2011Exploring the role of cognitive reserve in early-onset dementiaAm J Alzheimers Dis Other Demen26139144
43.
TuckerAMSternY2011Cognitive reserve in agingCurr Alzheimer Res8354360
44.
DavidsonYGibbonsLPritchardAHardicreJWrenJStopfordCJulienCThompsonJPaytonAPickering-BrownSMPendletonNHoranMABurnsAPurandareNLendonCLNearyDSnowdenJSMannDM2007Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer’s diseaseDement Geriatr Cogn Disord236066
45.
KleimanTZdanysKBlackBRightmerTGreyMGarmanKMacavoyMGelernterJvan DyckC2006Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer’s disease: Retrospective and prospective analysisDement Geriatr Cogn Disord227382
46.
BenkeTDelazerMSaninGSchmidtHSeilerSRansmayrGDal-BiancoPUranusMMarksteinerJLeblhuberFKapellerPBancherCSchmidtR2013Cognition, gender, and functional abilities in Alzheimer’s disease: How are they related?J Alzheimers Dis35247252
47.
PeresKHelmerCAmievaHMatharanFCarcaillonLJacqmin-GaddaHAuriacombeSOrgogozoJMBarberger-GateauPDartiguesJF2011Gender differences in the prodromal signs of dementia: Memory complaint and IADL-restriction. A prospective population-based cohortJ Alzheimers Dis273947
